Filing Details
- Accession Number:
- 0001193125-22-041883
- Form Type:
- 13G Filing
- Publication Date:
- 2022-02-13 19:00:00
- Filed By:
- Schoenberg Ido
- Company:
- American Well Corp (NYSE:AMWL)
- Filing Date:
- 2022-02-14
- SEC Url:
- 13G Filing
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| Ido Schoenberg | 15,835,079 | 15,835,079 | 15,835,079 | 6.5% | ||
| Roy Schoenberg | , | 16,432,148 | 16,432,148 | 6.7% |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
American Well Corporation
(Name of Issuer)
Class A Common Stock, par value $0.01 par value per share
(Title of Class of Securities)
03044L105
(CUSIP Number)
December 31, 2021
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ Rule 13d-1(b)
☐ Rule 13d-1(c)
☒ Rule 13d-1(d)
| * | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. |
The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
| SCHEDULE 13G | ||||
| 1 | NAME OF REPORTING PERSON OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Ido Schoenberg | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER
NONE | ||||
| 6 | SHARED VOTING POWER
15,835,079(1) | |||||
| 7 | SOLE DISPOSITIVE POWER
15,835,079 | |||||
| 8 | SHARED DISPOSITIVE POWER
NONE | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
15,835,079(1) | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.5%(2)(3) | |||||
| 12 | TYPE OF REPORTING PERSON
IN | |||||
| (1) | Consists of (i) 598,916 shares of Class A Common Stock, (ii) 13,232,870 shares of Class B Common Stock, (iii) 238,409 shares of Class B Common Stock to be issued pursuant to vesting of restricted stock units within 60 days of December 31, 2021 and (iv) 1,764,884 shares of Class B Common Stock underlying options that are currently exercisable. Each share of Class B Common Stock is convertible into one share of the Issuers Class A Common Stock at any time at the option of the holder thereof. Dr. Ido Schoenberg and Dr. Roy Schoenberg are parties to a voting agreement whereby each has agreed to vote their shares together as a group. Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg may be deemed to beneficially own each others stock with shared voting power, currently consisting in the aggregate of 1,347,062 shares of Class A Common Stock and 30,920,165 shares of Class B Common Stock. |
| (2) | Based on the quotient obtained by dividing (a) the aggregate number of Class A Common Stock and Class B Common Stock, together, beneficially owned by the Reporting Person as set forth in Row 9 by (b) the sum of (i) 229,402,453 shares of Class A Common Stock outstanding as of December 31, 2021 and (ii) the aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person. The aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person as set forth in clauses (a) and (b) of this footnote are treated as converted into shares of Class A Common Stock solely for the purpose of computing the percentage ownership of the Reporting Person. |
| CUSIP No. 03044L105 | SCHEDULE 13G | |||
| (3) | Each share of Class A Common Stock is entitled to one vote, and shares of Class B Common Stock will collectively be entitled to a number of votes equal to the product of (x) 1.0408163 and (y) the total number of votes that would be cast at such time by the holders of the Class A and Class C Common Stock and any other preferred stock entitled to vote under the Issuers certificate of incorporation at such time (resulting in the Class B Common Stock collectively holding 51% of the total outstanding voting power). Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg each own 25.5% of the total outstanding voting power, and based on their voting agreement, their interests collectively represent 51% of the aggregate voting power of the Issuers issued and outstanding share capital. |
3
| CUSIP No. 03044L105 | SCHEDULE 13G | |||
| 1 | NAME OF REPORTING PERSON OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Roy Schoenberg | |||||
| 2 | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) ☒ (b) ☐
| |||||
| 3 | SEC USE ONLY
| |||||
| 4 | CITIZENSHIP OR PLACE OF ORGANIZATION
United States | |||||
| NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH | 5 | SOLE VOTING POWER
NONE | ||||
| 6 | SHARED VOTING POWER
16,432,148(1) | |||||
| 7 | SOLE DISPOSITIVE POWER
16,432,148 | |||||
| 8 | SHARED DISPOSITIVE POWER
NONE | |||||
| 9 | AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,432,148(1) | |||||
| 10 | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
| 11 | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
6.7%(2)(3) | |||||
| 12 | TYPE OF REPORTING PERSON
IN | |||||
| (1) | Consists of (i) 748,146 shares of Class A Common Stock, (ii) 13,680,709 shares of Class B Common Stock, (iii) 238,409 shares of Class B Common Stock to be issued pursuant to vesting of restricted stock units within 60 days of December 31, 2021 and (iv) 1,764,884 shares of Class B Common Stock underlying options that are currently exercisable. Each share of Class B Common Stock is convertible into one share of the Issuers Class A Common Stock at any time at the option of the holder thereof. Dr. Ido Schoenberg and Dr. Roy Schoenberg are parties to a voting agreement whereby each has agreed to vote their shares together as a group. Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg may be deemed to beneficially own each others stock with shared voting power, currently consisting in the aggregate of 1,347,062 shares of Class A Common Stock and 30,920,165 shares of Class B Common Stock. |
| (2) | Based on the quotient obtained by dividing (a) the aggregate number of Class A Common Stock and Class B Common Stock, together, beneficially owned by the Reporting Person as set forth in Row 9 by (b) the sum of (i) 229,402,453 shares of Class A Common Stock outstanding as of December 31, 2021 and (ii) the aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person. The aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person as set forth in clauses (a) and (b) of this footnote are treated as converted into shares of Class A Common Stock solely for the purpose of computing the percentage ownership of the Reporting Person. |
4
| CUSIP No. 03044L105 | SCHEDULE 13G | |||
| (3) | Each share of Class A Common Stock is entitled to one vote, and shares of Class B Common Stock will collectively be entitled to a number of votes equal to the product of (x) 1.0408163 and (y) the total number of votes that would be cast at such time by the holders of the Class A and Class C Common Stock and any other preferred stock entitled to vote under the Issuers certificate of incorporation at such time (resulting in the Class B Common Stock collectively holding 51% of the total outstanding voting power). Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg each own 25.5% of the total outstanding voting power, and based on their voting agreement, their interests collectively represent 51% of the aggregate voting power of the Issuers issued and outstanding share capital. |
5
| CUSIP No. 03044L105 | SCHEDULE 13G | |||
| Item 1. | (a) NAME OF ISSUER |
American Well Corporation (the Company)
(b) ADDRESS OF ISSUERS PRINCIPAL EXECUTIVE OFFICES
75 State Street
26th Floor
Boston, MA 02109
| Item 2. | (a) NAMES OF PERSONS FILING |
This Statement is being filed on behalf of each of the following persons (collectively, the Reporting Persons):
| (i) | Ido Schoenberg |
| (ii) | Roy Schoenberg |
The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which the Reporting Persons have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.
(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE
The principal addresses of the Reporting Persons are as follows:
75 State Street
26th Floor
Boston, MA 02109
(c) CITIZENSHIP
| (i) | Ido Schoenberg United States |
| (ii) | Roy Schoenberg United States |
(d) TITLE OF CLASS OF SECURITIES
Class A common stock, par value $0.01 per share (the Shares)
(e) CUSIP NUMBER
03044L105
6
| CUSIP No. 03044L105 | SCHEDULE 13G | |||
| Item 3. | IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b) OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS: |
Not applicable.
| Item 4. | OWNERSHIP. |
| (a) | Amount Beneficially Owned as of December 31, 2021: |
(i) Ido Schoenberg: 15,835,079 Shares (1)
(ii) Roy Schoenberg: 16,432,148 Shares (2)
| (b) | Percentage Owned: |
(i) Ido Schoenberg: 6.5% (3)(4)
(ii) Roy Schoenberg: 6.7% (3)(4)
| (c) | Number of Shares as to Which Such Person Has: |
(i) sole power to vote or direct the vote of
(A) Ido Schoenberg: 0
(B) Roy Schoenberg: 0
(ii) shared power to vote or direct the vote of
(A) Ido Schoenberg: 15,835,079 (1)
(B) Roy Schoenberg: 16,432,148 (2)
(iii) sole power to dispose or to direct the disposition of
(A) Ido Schoenberg: 15,835,079
(B) Roy Schoenberg: 16,432,148
(iv) shared power to dispose or to direct the disposition of
(A) Ido Schoenberg: 0
(B) Roy Schoenberg: 0
Notes:
| (1) | Consists of (i) 598,916 shares of Class A Common Stock, (ii) 13,232,870 shares of Class B Common Stock, (iii) 238,409 shares of Class B Common Stock to be issued pursuant to vesting of restricted stock units within 60 days of December 31, 2021 and (iv) 1,764,884 shares of Class B Common Stock underlying options that are currently exercisable. Each share of Class B Common Stock is convertible into one share of the Issuers Class A Common Stock at any time at the option of the holder thereof. Dr. Ido Schoenberg and Dr. Roy Schoenberg are parties to a voting agreement whereby each has agreed to vote their shares together as a group. Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg may be deemed to beneficially own each others stock with shared voting power, currently consisting in the aggregate of 1,347,062 shares of Class A Common Stock and 30,920,165 shares of Class B Common Stock. |
| (2) | Consists of (i) 748,146 shares of Class A Common Stock, (ii) 13,680,709 shares of Class B Common Stock, (iii) 238,409 shares of Class B Common Stock to be issued pursuant to vesting of restricted stock |
7
| CUSIP No. 03044L105 | SCHEDULE 13G | |||
| units within 60 days of December 31, 2021 and (iv) 1,764,884 shares of Class B Common Stock underlying options that are currently exercisable. Each share of Class B Common Stock is convertible into one share of the Issuers Class A Common Stock at any time at the option of the holder thereof. Dr. Ido Schoenberg and Dr. Roy Schoenberg are parties to a voting agreement whereby each has agreed to vote their shares together as a group. Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg may be deemed to beneficially own each others stock with shared voting power, currently consisting in the aggregate of 1,347,062 shares of Class A Common Stock and 30,920,165 shares of Class B Common Stock. |
| (3) | Based on the quotient obtained by dividing (a) the aggregate number of Class A Common Stock and Class B Common Stock, together, beneficially owned by the Reporting Person as set forth in Row 9 by (b) the sum of (i) 229,402,453 shares of Class A Common Stock outstanding as of December 31, 2021, and (ii) the aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person. The aggregate number of shares of Class B Common Stock beneficially owned by the Reporting Person as set forth in clauses (a) and (b) of this footnote are treated as converted into shares of Class A Common Stock solely for the purpose of computing the percentage ownership of the Reporting Person. |
| (4) | Each share of Class A Common Stock is entitled to one vote, and shares of Class B Common Stock will collectively be entitled to a number of votes equal to the product of (x) 1.0408163 and (y) the total number of votes that would be cast at such time by the holders of the Class A and Class C Common Stock and any other preferred stock entitled to vote under the Issuers certificate of incorporation at such time (resulting in the Class B Common Stock collectively holding 51% of the total outstanding voting power). Accordingly, each of Dr. Ido Schoenberg and Dr. Roy Schoenberg each own 25.5% of the total outstanding voting power, and based on their voting agreement, their interests collectively represent 51% of the aggregate voting power of the Issuers issued and outstanding share capital. |
| Item 5. | OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS |
Not applicable.
| Item 6. | OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON |
Not applicable.
| Item 7. | IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY |
Not applicable.
| Item 8. | IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP |
See Item 4, which states the identity of the members of the group filing this Schedule 13G.
| Item 9. | NOTICE OF DISSOLUTION OF GROUP |
Not applicable.
| Item 10. | CERTIFICATION |
Not applicable.
8
| CUSIP No. 03044L105 | SCHEDULE 13G | |||
Exhibit Index
Exhibit 99.1. Joint Filing Agreement as required by Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended.
9
| SCHEDULE 13G | ||||
SIGNATURES
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Dated as of February 14, 2022
| IDO SCHOENBERG | ||
| By: | /s/ Ido Schoenberg | |
| ROY SCHOENBERG | ||
| By: | /s/ Roy Schoenberg | |
[Signature Page to Schedule 13G]